Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Total Debt (2019 - 2025)

Historic Total Debt for Vivos Therapeutics (VVOS) over the last 4 years, with Q3 2025 value amounting to $8.7 million.

  • Vivos Therapeutics' Total Debt changed N/A to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2021, which is 193.8% down from last year.
  • Vivos Therapeutics' Total Debt amounted to $8.7 million in Q3 2025.
  • Vivos Therapeutics' Total Debt's 5-year high stood at $8.7 million during Q3 2025, with a 5-year trough of $1.3 million in Q4 2021.